It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read MoreTop Stories
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Celebrating World Patient Safety Day 2024:
On World Patient Safety Day 2024, we focus on the critical...
Filter
The Business Case for Diversity, Equity, and Inclusion (DE&I) in the Pharma Industry
To learn how much businesses can gain from more diverse and inclusive workplaces and why...
Why Do Plain Language Clinical Trial Summaries Matter?
Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Leveraging Technology to Enhance Customer Experience – A 3-Pronged Approach for Medical Affairs
As digital technology changes everything from how drugs are discovered to how healthcare is delivered...
Reimagining the MSL-KOL Relationship
MSL-KOL relationships: Medical Affairs teams and KOLs believe that approximately 40-50% of future interactions will...
The Changing Environment of Medical Affairs and Need for Increased Customer-Centricity
Medical Affairs will soon emerge as a frontline strategic division and grow in stature as...
Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences
The growth and adoption of the internet and mobile technology have provided publishers and authors...